
In this part 2, Kirsten Axelsen, MS, discusses racial disparities, AI in prior authorization, and payers’ readiness for the next wave of CLL therapies.
Supplements and Featured Publications
This AJMC® Clinical Brief explores the latest evidence-based guidelines on the management of chronic obstructive pulmonary disease (COPD), recent research with real-world utilization data, and the implications of prescription and utilization patterns on COPD healthcare resource utilization and total cost of care.




